"Proud to lead the way in neurological care. Our doctors are dedicated to providing advanced diagnostic, treatment, and management options for your neurological concerns. Michael Amiri MD, DABSM Robert Nahouraii MD Matthew McConnell MD Betty Mays FNP-C Kelly Y. Xiong DNP, FNP-C Autumn Grimm FNP-C"

During the past decade, Mecklenburg Neurology Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mecklenburg Neurology Group" are "Acute Treatment of Migraine" (1 trials) and "Pediatric Migraine" (1 trials). Many other conditions were trialed in "Mecklenburg Neurology Group" in a lesser frequency.

Most popular intervention types in "Mecklenburg Neurology Group" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Matching placebo" (1 trials), "Rimegepant / BHV3000" (1 trials) and "Rimegepant/BHV3000" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mecklenburg Neurology Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mecklenburg Neurology Group". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Mecklenburg Neurology Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mecklenburg Neurology Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".